Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Translating tumor biology into personalized treatment planning: analytical performance characteristics of the Oncotype DX®Colon Cancer Assay

1 Dec 2010

Abstract excerpt

BACKGROUND: The Oncotype DX Colon Cancer Assay is a new diagnostic test for determining the likelihood of recurrence in stage II colon cancer patients after surgical resection using fixed paraffin embedded (FPE) primary colon tumor tissue. Like the Oncotype DX Breast Cancer Assay, this is a high complexity, multi-analyte, reverse transcription (RT) polymerase chain reaction (PCR) assay that measures the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Colorectal Cancer Surgical Treatments
Share to Genetic factors in colorectal cancer
Share to Molecular Biology Techniques and Applications

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 21176237
DOI: 10.1186/1471-2407-10-691

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Translating tumor biology into personalized treatment planning: analytical performance characteristics of the Oncotype DX®Colon Cancer AssayPMID 21176237Read ↗

Biomarker discovery for colon cancer using a 761 gene RT-PCR assaySemantic proximity Read ↗

Relationship Between Tumor Gene Expression and Recurrence in Four Independent Studies of Patients With Stage II/III Colon Cancer Treated With Surgery Alone or Surgery Plus Adjuvant Fluorouracil Plus LeucovorinSemantic proximity Read ↗

Validation study of a quantitative multigene reverse transcriptase-polymerase chain reaction assay for assessment of recurrence risk in patients with stage II colon cancer.Semantic proximity Read ↗

Young-Onset Colon Cancer and Recurrence Risk by Gene Expression.Semantic proximity Read ↗

Colorectal Cancer Recurrence Prediction Using a Tissue-Free Epigenomic Minimal Residual Disease AssaySemantic proximity Read ↗

Comparative economics of a 12-gene assay for predicting risk of recurrence in stage II colon cancer.Semantic proximity Read ↗

Common variation in a long non-coding RNA gene modulates variation of circulating TGF-<i>β</i>2 levels in metastatic colorectal cancer patients (Alliance)Semantic proximity Read ↗

Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.